Forbes - CARLSBAD, Calif., Oct. 26 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) announced today that CHDI, Inc. (CHDI), a non-profit foundation pursuing treatments for Huntington's Disease (HD), will provide up to $9.9 million in ...